• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

浆液性癌来源的去分化子宫内膜癌：诊断挑战与建议

Dedifferentiated endometrial carcinoma arising from serous carcinoma: Diagnostic challenges and recommendations.

作者信息

Xu Zhengfan, Saikia Kasturi, Yuan Lisi

机构信息

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, MI, USA.

出版信息

Gynecol Oncol Rep. 2023 Apr 13;47:101188. doi: 10.1016/j.gore.2023.101188. eCollection 2023 Jun.

DOI:10.1016/j.gore.2023.101188
PMID:37122437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10130470/
Abstract

•Dedifferentiated endometrial carcinoma arising from serous carcinoma (null-type P53).•Differential diagnosis including carcinosarcoma, FIGO grade 3 endometrioid carcinoma.•Also need to rule out SMARCA4-deficient uterine sarcoma and other sarcomas.

摘要

•由浆液性癌（P53 缺失型）引起的去分化子宫内膜癌。

•鉴别诊断包括癌肉瘤、国际妇产科联盟（FIGO）3 级子宫内膜样癌。

•还需要排除 SMARCA4 缺陷型子宫肉瘤和其他肉瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/10130470/dc26326a41f2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/10130470/be558c61d476/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/10130470/dc26326a41f2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/10130470/be558c61d476/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/10130470/dc26326a41f2/gr2.jpg

相似文献

1
Dedifferentiated endometrial carcinoma arising from serous carcinoma: Diagnostic challenges and recommendations.浆液性癌来源的去分化子宫内膜癌：诊断挑战与建议
Gynecol Oncol Rep. 2023 Apr 13;47:101188. doi: 10.1016/j.gore.2023.101188. eCollection 2023 Jun.
2
Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.子宫低级别子宫内膜样癌（包括混合性子宫内膜癌）的鉴别诊断问题：国际妇科病理学家协会的建议
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S25-S39. doi: 10.1097/PGP.0000000000000512.
3
Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma.高级别子宫内膜癌背景下发生的未分化子宫内膜癌——扩大去分化子宫内膜癌的定义。
Histopathology. 2020 Nov;77(5):769-780. doi: 10.1111/his.14186. Epub 2020 Sep 27.
4
[Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].[未分化和去分化子宫内膜癌：一种鉴别诊断范围广泛的罕见实体]
Pathologe. 2019 Nov;40(6):609-618. doi: 10.1007/s00292-019-00670-1.
5
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.p16 表达在鉴别子宫浆液性癌与子宫内膜样腺癌和宫颈内膜腺癌中的作用：201 例免疫组化分析。
Am J Surg Pathol. 2009 Oct;33(10):1504-14. doi: 10.1097/PAS.0b013e3181ac35f5.
6
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.高级别子宫内膜癌：形态学和免疫组化特征、诊断挑战与建议
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S40-S63. doi: 10.1097/PGP.0000000000000491.
7
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.子宫内膜腺癌的免疫表型多样性：对鉴别诊断的意义。
Mod Pathol. 2006 Aug;19(8):1091-100. doi: 10.1038/modpathol.3800620. Epub 2006 Apr 28.
8
Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.使用定制的小型癌症panel 对子宫内膜去分化癌、子宫内膜样癌、癌肉瘤和浆液性癌进行分子评估。
Pathol Oncol Res. 2021 Dec 23;27:1610013. doi: 10.3389/pore.2021.1610013. eCollection 2021.
9
Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.子宫和卵巢的混合性子宫内膜样腺癌和苗勒管腺肉瘤：强调与癌肉瘤鉴别诊断的临床病理特征。
Am J Surg Pathol. 2021 Mar 1;45(3):374-383. doi: 10.1097/PAS.0000000000001643.
10
Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.子宫浆液性癌是否存在诊断不足？高级别子宫内膜癌最初诊断为高级别子宫内膜样癌时的组织形态学和免疫组织化学相关性及临床随访。
Mod Pathol. 2018 Feb;31(2):358-364. doi: 10.1038/modpathol.2017.131. Epub 2017 Oct 6.

引用本文的文献

1
Establishment of Two Novel Ovarian Tumor Cell Lines with Characteristics of Mucinous Borderline Tumors or Dedifferentiated Carcinoma-Implications for Tumor Heterogeneity and the Complex Carcinogenesis of Mucinous Tumors.建立两种具有黏液性交界性肿瘤或去分化癌特征的新型卵巢肿瘤细胞系——对肿瘤异质性及黏液性肿瘤复杂癌变过程的启示
Cancers (Basel). 2025 May 20;17(10):1716. doi: 10.3390/cancers17101716.
2
Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review.围绝经期激素治疗期间诊断出的未分化子宫内膜癌：一例病例报告及文献综述
Front Oncol. 2024 Nov 22;14:1440246. doi: 10.3389/fonc.2024.1440246. eCollection 2024.

本文引用的文献

1
Uncommon and Difficult High-Grade Endometrial Carcinomas.罕见且具有挑战性的高级别子宫内膜癌。
Surg Pathol Clin. 2022 Jun;15(2):301-314. doi: 10.1016/j.path.2022.02.007. Epub 2022 May 20.
2
High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.高级别子宫内膜癌：形态学谱与分子分类
Semin Diagn Pathol. 2022 May;39(3):176-186. doi: 10.1053/j.semdp.2021.11.002. Epub 2021 Nov 20.
3
Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
TCGA 分类和 SWI/SNF 蛋白表达在未分化/去分化子宫内膜癌中的临床病理意义：一种可能的预后风险分层。
Gynecol Oncol. 2021 May;161(2):629-635. doi: 10.1016/j.ygyno.2021.02.029. Epub 2021 Mar 10.
4
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.当贝伐珠单抗联合化疗用于晚期/复发性子宫内膜癌时，突变型 p53 预示着结局的改善：NRG 肿瘤学研究。
Gynecol Oncol. 2021 Apr;161(1):113-121. doi: 10.1016/j.ygyno.2021.01.025. Epub 2021 Feb 2.
5
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 子宫内膜癌管理指南。
Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.
6
Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis.子宫内膜癌：分子亚型、前体及病理学在早期诊断中的作用。
J Pathol. 2021 Apr;253(4):355-365. doi: 10.1002/path.5608. Epub 2021 Feb 6.
7
Undifferentiated and dedifferentiated neoplasms of the female genital tract.女性生殖系统未分化和去分化肿瘤。
Semin Diagn Pathol. 2021 Nov;38(6):137-151. doi: 10.1053/j.semdp.2020.11.002. Epub 2020 Nov 27.
8
SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.SWI/SNF 缺陷定义了高度侵袭性的未分化子宫内膜癌。
J Pathol Clin Res. 2021 Mar;7(2):144-153. doi: 10.1002/cjp2.188. Epub 2020 Oct 30.
9
DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.与传统型癌肉瘤相比，存在 DNA 错配修复缺陷的子宫内膜癌肉瘤具有明显不同的临床、形态学和分子特征。
Am J Surg Pathol. 2020 Nov;44(11):1573-1579. doi: 10.1097/PAS.0000000000001561.
10
Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma.高级别子宫内膜癌背景下发生的未分化子宫内膜癌——扩大去分化子宫内膜癌的定义。
Histopathology. 2020 Nov;77(5):769-780. doi: 10.1111/his.14186. Epub 2020 Sep 27.